APA

van der Galiën H. T., Hoogendoorn M., Kibbelaar R. E., van Meerten T. & van Rijn R. S. (20191018). Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

van der Galiën H T, Hoogendoorn M, Kibbelaar R E, van Meerten T and van Rijn R S. 20191018. Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

van der Galiën H. T., Hoogendoorn M., Kibbelaar R. E., van Meerten T. and van Rijn R. S. (20191018). Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

van der Galiën H T, Hoogendoorn M, Kibbelaar R E, van Meerten T and van Rijn R S. Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting. : Annals of oncology : official journal of the European Society for Medical Oncology. 20191018.